Skip to main content

Best Practices

At the Association of Community Cancer Centers 49th Annual Meeting & Cancer Business Summit, Andre Harvin, PharmD, MS, MBA, Executive Director of Pharmacy, Oncology Services, Cone Health Cancer Center, Greensboro, NC, presented a keynote lecture titled, “Robots, Biologics, and Advocates: Lessons from the Pharmacy.” Read More ›

On June 1, 2008, the United States Pharmacopeia (USP) General Chapter 797 Pharmaceutical Compounding – Sterile Compounding (USP ) was made official. Read More ›

Although the role of biosimilars in the treatment of patients with cancer has been under review by payers and providers for several years, there remains conflicting application regarding policy and strategy. Read More ›

Biosimilars have the potential to create a more sustainable healthcare environment by offering substantial cost-savings and expanding patient access to life-saving therapies. Read More ›

The advent of biologic drugs has had a significant impact on the management of patients with cancer. However, the high costs associated with these agents can hinder treatment access for many patients and place a significant burden on healthcare systems. Read More ›

Complying with Pharmacy Standards: USP 797/USP 800

Three cancer centers share their experiences related to the struggle of understanding wide variations in the application of sterile compounding and safe handling of oncology hazardous drugs, and the costs and operating burdens of compliance with and adherence to current pharmacy standards.

Read More ›

Using Cancer Drugs Wisely to Control Costs: Targeted Therapies May Hold the Key

“It is time for us to bury the concept of maximum-tolerated dose in the world of targeted therapy,” according to Allen S. Lichter, MD, FASCO.

Read More ›

A persistent medi­­cation safety issue is getting the attention it has long deserved. In an effort to save lives related to the accidental intrathecal dosing of vincristine, the National Comprehensive Cancer Network (NCCN) has launched a program called “Just Bag It: The NCCN Campaign for Safe Handling of Vincristine." Read More ›

Hollywood, FL—Results from a survey of oncology pharmacists from across the country indicate that the verification process for chemotherapy orders is not uniformly electronic. In fact, >25% of responders are still using paper orders, said Carly Duncan, PharmD candidate, of the Cleveland Clinic Florida, Weston. She presented findings from her and her colleagues’ survey at the 2016 annual conference of the National Comprehensive Cancer Network.

Read More ›

Lymphomas are a group of blood cancers that originate in the lymphatic system. The primary function of this system is to help the body fight infection. Read More ›

Page 1 of 3